Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 6, 17-25

Eosinophil Apoptosis and Clearance in Asthma


Eosinophil Apoptosis and Clearance in Asthma

Garry M Walsh. J Cell Death.


Asthma is an increasingly common respiratory condition characterized by reversible airway obstruction, bronchial hyper-responsiveness and airway inflammation with a clear unmet need for more effective therapy. Eosinophilic asthma is a phenotype of the condition that features increased blood or sputum eosinophils whose numbers correlate with disease severity. Several lines of evidence are now emerging, which implicate increased persistence of eosinophils in the lungs of patients with asthma as a consequence of inhibition of and defects in the apoptotic process, together with impaired apoptotic cell removal mechanisms. This article will update our knowledge of the mechanisms controlling eosinophil apoptosis and clearance, together with evidence implicating defects in apoptosis and pro-inflammatory cell removal in asthma. Recent developments in novel therapies for asthma that target eosinophil apoptotic and/or clearance pathways will also be discussed.

Keywords: apoptosis; eosinophil; phagocytic removal.

Similar articles

See all similar articles

Cited by 13 PubMed Central articles

See all "Cited by" articles


    1. Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev. 2011;242(1):31–50. - PubMed
    1. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J. 2005;25:552–63. - PubMed
    1. Holtzman MJ. Drug development for asthma. Am J Resp Cell Mol Biol. 2003;29:163–71. - PubMed
    1. Berger WE. New approaches to managing asthma: A US perspective. Therap Clin Risk Management. 2008;4:363–79. - PMC - PubMed
    1. Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81–121. - PMC - PubMed

LinkOut - more resources